Epigenetic Reprogramming of CD4
Animals
Antineoplastic Agents
/ adverse effects
Cell Differentiation
/ drug effects
Cellular Reprogramming
/ drug effects
Epigenesis, Genetic
/ drug effects
Humans
Immunotherapy, Adoptive
/ adverse effects
Lymphocytes, Tumor-Infiltrating
/ drug effects
Neoplasms
/ genetics
T-Lymphocytes, Helper-Inducer
/ drug effects
Treatment Outcome
Tumor Microenvironment
CD4+ helper T cells
epigenetics
immunotherapy
plasticity
tumor microenvironment
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
02
2021
accepted:
15
06
2021
entrez:
15
7
2021
pubmed:
16
7
2021
medline:
21
10
2021
Statut:
epublish
Résumé
Evidences highlight the role of various CD4
Identifiants
pubmed: 34262562
doi: 10.3389/fimmu.2021.669992
pmc: PMC8273698
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
669992Informations de copyright
Copyright © 2021 Renaude, Kroemer, Borg, Peixoto, Hervouet, Loyon and Adotévi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nature. 2017 Aug 10;548(7666):228-233
pubmed: 28783731
Nature. 2012 Jul 12;487(7406):249-53
pubmed: 22763435
Cancer Gene Ther. 2021 Feb;28(1-2):5-17
pubmed: 32457487
Oncogene. 2015 Dec 3;34(49):5960-70
pubmed: 25745993
Vaccines (Basel). 2015 Jun 30;3(3):490-502
pubmed: 26350591
Int J Mol Sci. 2020 Feb 29;21(5):
pubmed: 32121394
J Leukoc Biol. 2019 Feb;105(2):243-255
pubmed: 30387907
Cancer Res. 2010 Nov 1;70(21):8368-77
pubmed: 20940398
Nat Commun. 2018 Apr 12;9(1):1424
pubmed: 29651155
Immunity. 2017 Nov 21;47(5):848-861.e5
pubmed: 29126798
Cell Metab. 2015 Nov 3;22(5):861-73
pubmed: 26411344
Br J Cancer. 2019 Jan;120(1):3-5
pubmed: 30413824
Blood. 2012 Mar 15;119(11):2443-51
pubmed: 22246031
Int J Mol Sci. 2011;12(11):7424-37
pubmed: 22174607
J Clin Oncol. 2009 Jan 10;27(2):186-92
pubmed: 19064967
J Immunol. 2015 Mar 1;194(5):2049-56
pubmed: 25710958
J Immunol. 2008 Dec 15;181(12):8372-81
pubmed: 19050254
N Engl J Med. 2012 Jun 28;366(26):2455-65
pubmed: 22658128
Front Biosci (Landmark Ed). 2017 Jan 1;22:644-668
pubmed: 27814638
Nat Commun. 2019 Mar 29;10(1):1424
pubmed: 30926808
J Exp Med. 2009 Jul 6;206(7):1457-64
pubmed: 19564351
Ther Adv Med Oncol. 2018 Aug 29;10:1758835918793105
pubmed: 30181782
J Immunol. 2006 Jul 15;177(2):896-904
pubmed: 16818744
Cancer Immunol Res. 2018 Dec;6(12):1578-1592
pubmed: 30396909
Immunol Rev. 2017 Mar;276(1):80-96
pubmed: 28258692
Immunity. 2016 Feb 16;44(2):316-29
pubmed: 26872697
Nat Med. 2007 Nov;13(11):1299-307
pubmed: 17922010
Immunol Cell Biol. 2015 Aug;93(7):662-72
pubmed: 25823994
Cancer Res. 2009 Jan 15;69(2):599-608
pubmed: 19147574
Cancer Immunol Res. 2018 Oct;6(10):1234-1245
pubmed: 30087114
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11410-5
pubmed: 15272080
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3880-5
pubmed: 15004274
Cell Immunol. 2017 Dec;322:15-25
pubmed: 29103586
Immunity. 2010 May 28;32(5):616-27
pubmed: 20471290
Clin Cancer Res. 2008 Jun 1;14(11):3254-61
pubmed: 18519750
Sci Immunol. 2020 Oct 30;5(52):
pubmed: 33127608
Eur J Immunol. 2011 Apr;41(4):936-51
pubmed: 21381020
JCI Insight. 2018 May 17;3(10):
pubmed: 29769444
Curr Opin Immunol. 2017 Aug;47:85-92
pubmed: 28755541
Cancer Immunol Immunother. 2019 Mar;68(3):379-393
pubmed: 30547218
Nat Med. 2019 Mar;25(3):470-476
pubmed: 30742120
J Hepatol. 2009 May;50(5):980-9
pubmed: 19329213
Semin Cancer Biol. 2020 Oct;65:80-90
pubmed: 31705998
Oncotarget. 2021 May 11;12(10):967-981
pubmed: 34012510
Epigenomics. 2020 Nov;12(21):1871-1882
pubmed: 33169618
J Clin Invest. 2013 Jul;123(7):2873-92
pubmed: 23778140
Nat Med. 2019 Mar;25(3):477-486
pubmed: 30742122
Biochem Biophys Res Commun. 2011 Apr 8;407(2):348-54
pubmed: 21396350
Immunity. 2019 Dec 17;51(6):1028-1042.e4
pubmed: 31810883
Nat Rev Clin Oncol. 2017 Dec;14(12):717-734
pubmed: 28741618
Immunity. 2016 Nov 15;45(5):1148-1161
pubmed: 27851915
Oncoimmunology. 2017 Nov 13;7(2):e1393596
pubmed: 29308326
Nature. 2020 Nov;587(7832):115-120
pubmed: 33087928
Adv Exp Med Biol. 2014;841:15-44
pubmed: 25261203
Int J Cancer. 2010 Jun 1;126(11):2635-43
pubmed: 19856313
Nat Commun. 2014 Dec 22;5:5780
pubmed: 25531312
Immunity. 2009 Jan 16;30(1):155-67
pubmed: 19144320
Mol Immunol. 2007 Mar;44(9):2249-56
pubmed: 17166591
Immunity. 2017 Jan 17;46(1):51-64
pubmed: 28099864
Cancer Discov. 2014 Nov;4(11):1290-8
pubmed: 25182153
Oncol Lett. 2018 Nov;16(5):6215-6227
pubmed: 30405758
J Exp Med. 2006 Jun 12;203(6):1493-505
pubmed: 16717115
J Exp Med. 2010 Mar 15;207(3):651-67
pubmed: 20156973
Nat Rev Immunol. 2004 Aug;4(8):595-602
pubmed: 15286726
Nucleic Acids Res. 2016 Sep 6;44(15):7173-88
pubmed: 27141965
Nat Rev Clin Oncol. 2019 Jun;16(6):356-371
pubmed: 30705439
Cancer Res. 2011 Jul 15;71(14):4790-8
pubmed: 21646476
Annu Rev Immunol. 2012;30:707-31
pubmed: 22224760
Nat Rev Cancer. 2016 Apr;16(4):219-33
pubmed: 26965076
J Immunol. 2014 Nov 15;193(10):4988-99
pubmed: 25305313
Oncotarget. 2017 Dec 12;8(69):114156-114172
pubmed: 29371976
Nature. 2015 Nov 12;527(7577):249-53
pubmed: 26503055
Sci Rep. 2015 Nov 09;5:16355
pubmed: 26549310
Genome Res. 2009 Jul;19(7):1165-74
pubmed: 19494038
J Immunol. 2010 Mar 1;184(5):2281-8
pubmed: 20118280
J Med Chem. 2020 Nov 12;63(21):12460-12484
pubmed: 32608981
Cell. 2019 Nov 14;179(5):1177-1190.e13
pubmed: 31730856
Nature. 2017 May 4;545(7652):98-102
pubmed: 28445461
Cell Res. 2006 Jan;16(1):3-10
pubmed: 16467870
Nature. 2006 Jul 6;442(7098):91-5
pubmed: 16728978
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
Oncol Rep. 2005 Jun;13(6):1153-8
pubmed: 15870936
Cell. 2015 Aug 27;162(5):961-73
pubmed: 26317465
Int J Cancer. 1990 Jun 15;45(6):1169-76
pubmed: 2112515
Cancer Immunol Res. 2014 Feb;2(2):91-8
pubmed: 24778273
Immunity. 2013 Oct 17;39(4):782-95
pubmed: 24138885
Clin Cancer Res. 2020 Feb 1;26(3):704-716
pubmed: 31645354
J Immunol. 2008 May 1;180(9):5916-26
pubmed: 18424711
J Immunother. 2010 Oct;33(8):828-33
pubmed: 20842054
Immunity. 2013 Nov 14;39(5):819-32
pubmed: 24238339
Blood. 2013 May 2;121(18):3631-9
pubmed: 23444399
Mol Oncol. 2021 Mar 26;:
pubmed: 33773029
Cell. 2002 Nov 1;111(3):285-91
pubmed: 12419240
Immunity. 2020 Jan 14;52(1):55-81
pubmed: 31940273
J Cancer. 2020 Apr 6;11(14):4059-4072
pubmed: 32368288
Nat Immunol. 2011 Jan;12(1):96-104
pubmed: 21151104
Front Immunol. 2014 Nov 28;5:614
pubmed: 25506346
Biochem Biophys Res Commun. 2017 Nov 4;493(1):1-8
pubmed: 28859982
J Immunol. 2015 Feb 1;194(3):878-82
pubmed: 25548231
J Exp Med. 2011 Mar 14;208(3):469-78
pubmed: 21339327
Nat Cancer. 2021 Apr;2(4):444-456
pubmed: 33899001
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Science. 2005 Jan 21;307(5708):430-3
pubmed: 15662016
EMBO Mol Med. 2019 Jul;11(7):e10293
pubmed: 31273938
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
Curr Opin Immunol. 2009 Apr;21(2):200-8
pubmed: 19285848
J Clin Invest. 2018 Aug 31;128(9):3813-3818
pubmed: 29905573
J Biol Chem. 2004 Sep 24;279(39):40640-6
pubmed: 15280353
Immunol Rev. 2017 Mar;276(1):97-111
pubmed: 28258697
Cell. 2017 Jan 26;168(3):487-502.e15
pubmed: 28111070
Nat Commun. 2021 Jan 18;12(1):409
pubmed: 33462245
Nat Commun. 2018 Dec 21;9(1):5452
pubmed: 30575739
J Immunol. 2010 Nov 15;185(10):6348-54
pubmed: 20952674
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
Genetics. 2013 Mar;193(3):651-69
pubmed: 23463798
Cell Rep. 2018 Jun 12;23(11):3262-3274
pubmed: 29898397
Cell Mol Immunol. 2020 Mar;17(3):247-260
pubmed: 30842630
J Allergy Clin Immunol. 2010 Jan;125(1):222-30.e1-4
pubmed: 20109749
IUBMB Life. 2000 Jun;49(6):473-8
pubmed: 11032239
Immunity. 2010 May 28;32(5):605-15
pubmed: 20493732
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373